Forma Therapeutics Holdings, Inc. 3 SEC Filings

Filed On	Filing
12 Jul 2022	Form 3: Melian Agustin, EVP, Research & Development No securities owned
13 Jan 2022	Form 3: Molina Arturo Md, Director No securities owned
19 Nov 2021	Form 3: Lesser Brian Andrew, SVP, Commercial Officer Holds 12,100 shares of Common Stock
15 Jun 2021	Form 3: Bishop John E, Chief Technology Officer No securities owned
11 Jan 2021	Form 3: Vickers Selwyn M Md, Director No securities owned
09 Sep 2020	Form 3: Wiggans Thomas G, Director No securities owned
30 Jul 2020	Form 3: Frederick Wayne A.i., Director No securities owned
18 Jun 2020	Form 3: Clackson Timothy P, Director Holds 21,572 shares of Enterprise 5 Junior Stock
18 Jun 2020	Form 3: Kolchinsky Peter, Director
18 Jun 2020	Form 3: Fanucci Marsha, Director Holds 26,547 shares of Enterprise 2 Junior Stock
18 Jun 2020	Form 3: Kelly Patrick F., SVP, Chief Medical Officer Holds 13,042 shares of Enterprise 3 Junior Stock
18 Jun 2020	Form 3: Wirth Peter, Director Holds 64,366 shares of Common Stock
18 Jun 2020	Form 3: Cook David N, SVP, Chief Scientific Officer
18 Jun 2020	Form 3: Hall Steven Edward, Director Holds 297,241 shares of Common Stock
18 Jun 2020	Form 3: Shegog Todd, SVP, Chief Financial Officer
18 Jun 2020	Form 3: Ra Capital MANAGEMENT, L.p., 10% owner and 2 others
18 Jun 2020	Form 3: Paoletti Paolo, Director Holds 19,841 shares of Enterprise 2 Junior Stock
18 Jun 2020	Form 3: Potts Jeannette, See Remarks
18 Jun 2020	Form 3: Wadlinger Mary E., See Remarks Holds 72,201 shares of Enterprise 2 Junior Stock
18 Jun 2020	Form 3: Wellington Biomedical Innovation Master Investors (Cayman) I L.p., 10% owner

Comments